Depression and Anxiety Trial, Recruiting NCT05754151 Sponsor: Weill Medical College of Cornell University Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT05754151
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 40 years of age or older
  • People who have been clinically assessed as having a primary diagnosis of an anxiety or depressive disorder, with a severity rating of 4 or higher on a standard diagnostic interview tool called the ADIS
  • People whose memory and thinking abilities, as measured by a standard test called the MMSE, fall within a normal range for their age and level of education
  • People who have access to an Apple iPhone, iPad, or Android device

Who may not be able to join:

  • People who have ever been diagnosed with a bipolar disorder or a psychotic disorder
  • People who are currently receiving cognitive behavioural therapy (a type of talking therapy)
  • People whose dose of a psychiatric medication has changed in the past 12 weeks
  • People who have started any form of psychotherapy in the past 12 weeks
  • People who currently have thoughts or a plan to attempt suicide

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jennifer Bress, Ph.D., Weill Medical College of Cornell University

Phone: (646) 289-5271

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
16 June 2023
Est. completion
1 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Acceptability of the MAYA application as measured by mean uMARS scores at Baseline; Acceptability of the MAYA application as measured by mean uMARS scores at Midpoint; Acceptability of the MAYA application as measured by mean uMARS scores at Endpoint; Feasibility of the MAYA application as measured by total number of sessions completed in the MAYA application at Endpoint; Feasibility of the MAYA application as measured by total number of sessions completed in the MAYA application at Follow Up

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov